Literature DB >> 2853702

Phospholipid modulates in vitro replication of autonomous replicating sequence from human cells.

H Umekawa1, K Tamiya-Koizumi, E Takagi, H Ariga, K Kojima, S Yoshida.   

Abstract

A cloned plasmid, pmyc(H-K), containing sequences derived from human c-myc gene replicated in vitro in Raji nuclear extract in a semiconservative manner. Using this system, it was found that phosphatidylinositol and cardiolipin strongly inhibited the replication of pmyc(H-K) in vitro, whereas other phospholipids, i.e., phosphatidylserine, phosphatidylcholine, phosphatidylethanolamine, phosphatidic acid, and sphingomyelin, had no appreciable effect. The concentrations of phosphatidylinositol and cardiolipin producing 50% inhibition of the replication were 4.6 and 5.4 microM, respectively. Phosphatidylinositol and cardiolipin inhibited the relaxation of pmyc(H-K) supercoiled DNA, but showed little or weaker effects on DNA polymerase alpha and topoisomerase II in Raji nuclear extract. These results suggest that phosphatidylinositol and cardiolipin antagonize the replication of pmyc(H-K) in vitro, through, at least in part, the interaction with topoisomerase I.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2853702     DOI: 10.1093/oxfordjournals.jbchem.a122469

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  3 in total

1.  Cloned origin of DNA replication in c-myc gene can function and be transmitted in transgenic mice in an episomal state.

Authors:  K Sudo; M Ogata; Y Sato; S M Iguchi-Ariga; H Ariga
Journal:  Nucleic Acids Res       Date:  1990-09-25       Impact factor: 16.971

2.  Inhibition of Escherichia coli DNA topoisomerase I activity by phospholipids.

Authors:  T Mizushima; S Natori; K Sekimizu
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

3.  DNA replication origin and transcriptional enhancer in c-myc gene share the c-myc protein binding sequences.

Authors:  H Ariga; Y Imamura; S M Iguchi-Ariga
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.